top of page

The Rise and Fall of Unicorn TeleHealth Startup Babylon Health

Babylon Health was founded in 2013 by Ali Parsa, a former NHS doctor. Parsa had the vision of creating a healthcare system that was accessible and affordable to everyone. He believed that AI could play a vital role in achieving this goal.

Babylon also began to develop an AI-powered symptom checker that could be used to diagnose and treat common illnesses.

The Rise and Fall of Unicorn TeleHealth Startup Babylon Health | The Business Anecdote

In 2016, Babylon Health's GP at Hand app was launched. The app allowed patients to consult with doctors via video calls and receive prescriptions for medication. The app was initially available only in London but later expanded to other parts of the UK. Babylon Health quickly gained popularity and attracted significant investments from venture capitalists. The company raised over $1.2 billion in funding over 8 rounds. The company’s investors included Saudi Arabia’s sovereign wealth fund, the Public Investment Fund, and other notable investors such as AlbaCore Capital, Swedbank Robur, and Kinnevik AB. This funding allowed Babylon to expand its operations rapidly and to attract top talent.


In 2019, the company was valued at nearly $2 billion after being backed by the likes of the founders of DeepMind and deep-pocketed health insurance companies. However, the company's fortunes began to decline soon after. By 2020, Babylon Health was facing criticism from the UK's Care Quality Commission (CQC) over its clinical safety and governance processes. The CQC found that the company had failed to meet several standards related to patient safety and risk management. The regulator also raised concerns about the accuracy of Babylon Health's AI-powered chatbot, which was used to triage patients.


In 2021, Babylon went public on the New York Stock Exchange. However, the IPO was a disaster. Babylon's stock price plummeted shortly after the IPO, and the company's valuation was slashed. The company lost money heavily, and its stock price continued to decline. The company had been struggling financially for some time due to mounting losses and legal disputes with insurers. Babylon's financial problems continued to worsen in 2022. The company had loss major contracts in its home market, including the NHS deal with Wolverhampton. In August 2022, Babylon Health announced cuts to its NHS GP at Hand service in Birmingham as it was not profitable. The company also ended a ten-year partnership with the Royal Wolverhampton NHS Trust after only two years, as it was not making enough revenue.


In May 2023, Babylon Health announced its plans to go private and accepted a take-private proposal from AlbaCore Capital on behalf of its affiliate MindMaze. The deal included a secured term loan facility for up to $34.5 million and Babylon’s transition from a publicly traded company to a private entity. Babylon also planned to merge with MindMaze. However, the deal fell through and was called off in June 2023 without explanation


In October 2023, Babylon Health sold its assets to eMed Healthcare UK after going bankrupt. The company’s collapse follows the loss of most of its £3.2 billion valuation. The sale excluded the GP at Hand app, which remains operational. The company's quiet exit from all but one of its NHS projects may be welcomed by some who saw the AI health care company as an example of privatization in the UK’s public health system.


Babylon Health filed for bankruptcy in the United States on August 9, 2023. The British subsidiary of the company formally went into administration on August 31, 2023. The administrators who sold a large chunk of Babylon Health’s assets to eMed Healthcare UK, said in a short statement that Babylon Healthcare Services Limited — the piece eMed is buying — covers the majority of what was left of Babylon Health, including a preventative telehealth practice that currently serves some 700,000 people in the UK through contracts with major providers like the private healthcare group Bupa.


The rise and fall of Babylon Health is a cautionary tale for the health tech industry. It shows that companies need to be honest and transparent about their products and services. It also shows that AI-powered healthcare tools need to be carefully evaluated before they are widely adopted. One of the main reasons for Babylon Health's collapse was their failed IPO. It is important that companies don't rush into up scaling their business or going public. This is not to say Babylon Health wasn't ready to go public. Maybe they should have addressed the growing concerns about their product before going public.


 

Source

(1) The Rise and Fall of Babylon Health: A Failed Tele-health Startup Goes .... https://robots.net/news/the-rise-and-fall-of-babylon-health-a-failed-tele-health-startup-goes-bankrupt/.

(2) Babylon Disrupted the UK’s Health System. Then It Left. https://www.wired.com/story/babylon-disrupted-uk-health-system-then-left/.

(4) The Rise and Fall of Babylon Health: From Tele-Health Startup to Insolvency. https://www.claytoncountyregister.com/news2/unicorn-medtech-startup-babylon-goes-bankrupt/198530/.

(6) The rise — and fall — of Babylon | Sifted. https://sifted.eu/articles/the-rise-and-fall-of-babylon.


Commentaires


bottom of page